{"id":30604,"date":"2025-01-29T10:43:12","date_gmt":"2025-01-29T09:43:12","guid":{"rendered":"https:\/\/ggba.swiss\/chuv-becomes-first-swiss-hospital-to-produce-gut-balancing-medication\/"},"modified":"2025-01-29T10:52:06","modified_gmt":"2025-01-29T09:52:06","slug":"le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/","title":{"rendered":"Le CHUV produit le premier m\u00e9dicament suisse r\u00e9\u00e9quilibrant le microbiote intestinal"},"content":{"rendered":"\n<p>La TMF permet de r\u00e9tablir l\u2019\u00e9quilibre intestinal d\u2019un patient en utilisant des d\u00e9p\u00f4ts biologiques soigneusement s\u00e9lectionn\u00e9s provenant d\u2019un donneur en parfaite sant\u00e9. Transform\u00e9s en m\u00e9dicament r\u00e9glement\u00e9, ces pr\u00e9cieux \u00e9chantillons sont administr\u00e9s sous forme de g\u00e9lules \u00e0 avaler ou achemin\u00e9s par des voies plus directes pour garantir que le microbiote atteigne sa destination avec efficacit\u00e9. Affichant un taux de r\u00e9ussite de 95%, contre seulement 30% pour les antibiotiques, cette approche a boulevers\u00e9 la prise en charge des patients aux intestins capricieux. Beaucoup rapportent une am\u00e9lioration quasi imm\u00e9diate, retrouvant un confort digestif en une nuit seulement.<\/p>\n\n\n\n<p>Contrairement \u00e0 d\u2019autres pays o\u00f9 le microbiote f\u00e9cal est class\u00e9 comme un tissu biologique, la r\u00e9glementation suisse le consid\u00e8re comme un m\u00e9dicament non standardisable, n\u00e9cessitant des proc\u00e9dures de fabrication et de contr\u00f4le qualit\u00e9 dignes de l\u2019industrie pharmaceutique. Le laboratoire d\u00e9di\u00e9 du <a href=\"https:\/\/www.chuv.ch\/fr\/chuv-home\/\">CHUV<\/a> applique des crit\u00e8res de s\u00e9lection stricts, garantissant que seuls les \u00e9chantillons les plus frais et les plus \u00e9quilibr\u00e9s soient utilis\u00e9s. Les donneurs sont soumis \u00e0 des tests cliniques et de laboratoire rigoureux, et seulement 10% d\u2019entre eux sont retenus. Chaque donneur agr\u00e9\u00e9 fournit en moyenne huit pr\u00e9l\u00e8vements par mois, permettant de produire une douzaine de traitements, utilisables pendant deux ans.<\/p>\n\n\n\n<h4 class=\"wp-block-heading\">Un acc\u00e8s \u00e9largi et un champ de recherche en pleine expansion<\/h4>\n\n\n\n<p>Le programme TMF du CHUV est le fruit d\u2019une collaboration multidisciplinaire entre les services des maladies infectieuses et de pharmacie. Maintenant que l\u2019autorisation de mise sur le march\u00e9 est obtenue, l\u2019h\u00f4pital entend \u00e9tendre l\u2019acc\u00e8s \u00e0 ce traitement \u00e0 d\u2019autres \u00e9tablissements en Suisse, permettant \u00e0 davantage de patients d\u2019en b\u00e9n\u00e9ficier. Selon la Dre Katerina Tatiana Galperine, responsable du projet TMF, la prise en charge par l\u2019assurance de base est cruciale pour assurer la p\u00e9rennit\u00e9 du traitement. Une demande est en cours aupr\u00e8s de l\u2019Office f\u00e9d\u00e9ral de la sant\u00e9 publique (OFSP) afin de garantir le remboursement des co\u00fbts pour les patients concern\u00e9s.<\/p>\n\n\n\n<p>Au-del\u00e0 de son application actuelle contre <em>Clostridioides difficile<\/em>, le CHUV explore d\u00e9j\u00e0 de nouvelles pistes dans la recherche sur le microbiote. Gr\u00e2ce \u00e0 son Centre TMF d\u00e9di\u00e9, des scientifiques \u00e9tudient d\u2019autres applications m\u00e9dicales potentielles, assurant ainsi \u00e0 la Suisse de rester \u00e0 l\u2019avant-garde des innovations en mati\u00e8re de sant\u00e9 intestinale.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Le CHUV a obtenu l\u2019autorisation de mise sur le march\u00e9 de Swissmedic pour produire un m\u00e9dicament de transplantation de microbiote f\u00e9cal (TMF), devenant ainsi le premier centre accr\u00e9dit\u00e9 en Suisse \u00e0 fabriquer ce traitement selon des normes pharmaceutiques strictes. Cette avanc\u00e9e offre une solution efficace aux patients souffrant d\u2019infections r\u00e9currentes \u00e0 Clostridioides difficile, une affection invalidante qui provoque de violents d\u00e9r\u00e8glements digestifs et un inconfort s\u00e9v\u00e8re.<\/p>\n","protected":false},"author":6,"featured_media":30601,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1169,1162,1188,1141,1171],"class_list":["post-30604","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr-2","tag-education-en-fr","tag-healthcare-fr-2","tag-personalized-medicine-fr-2","tag-pharma-fr-2"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Un m\u00e9dicament pour r\u00e9\u00e9quilibrer le microbiote intestinal au CHUV<\/title>\n<meta name=\"description\" content=\"Le CHUV a obtenu l\u2019autorisation de mise sur le march\u00e9 de Swissmedic pour produire un m\u00e9dicament de transplantation de microbiote f\u00e9cal (TMF).\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Un m\u00e9dicament pour r\u00e9\u00e9quilibrer le microbiote intestinal au CHUV\" \/>\n<meta property=\"og:description\" content=\"Le CHUV a obtenu l\u2019autorisation de mise sur le march\u00e9 de Swissmedic pour produire un m\u00e9dicament de transplantation de microbiote f\u00e9cal (TMF).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2025-01-29T09:43:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-01-29T09:52:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/CHUV-poop-medicine-1180x811-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"Le CHUV produit le premier m\u00e9dicament suisse r\u00e9\u00e9quilibrant le microbiote intestinal\",\"datePublished\":\"2025-01-29T09:43:12+00:00\",\"dateModified\":\"2025-01-29T09:52:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/\"},\"wordCount\":419,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/CHUV-poop-medicine-1180x811-1.jpg\",\"keywords\":[\"Biotech\",\"Education\",\"Healthcare\",\"Personalized Medicine\",\"Pharma\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/\",\"name\":\"Un m\u00e9dicament pour r\u00e9\u00e9quilibrer le microbiote intestinal au CHUV\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/CHUV-poop-medicine-1180x811-1.jpg\",\"datePublished\":\"2025-01-29T09:43:12+00:00\",\"dateModified\":\"2025-01-29T09:52:06+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"Le CHUV a obtenu l\u2019autorisation de mise sur le march\u00e9 de Swissmedic pour produire un m\u00e9dicament de transplantation de microbiote f\u00e9cal (TMF).\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/CHUV-poop-medicine-1180x811-1.jpg\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/CHUV-poop-medicine-1180x811-1.jpg\",\"width\":1180,\"height\":811,\"caption\":\"Gr\u00e2ce \u00e0 la pr\u00e9cision suisse et \u00e0 une r\u00e9glementation rigoureuse, le CHUV veille \u00e0 ce que seuls les microbiotes les plus sains et les plus \u00e9quilibr\u00e9s soient utilis\u00e9s, permettant aux patients de retrouver un transit harmonieux et de tirer un trait sur leurs d\u00e9sagr\u00e9ments. | \u00a9 CHUV \/ Ganguillet Apicha\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Le CHUV produit le premier m\u00e9dicament suisse r\u00e9\u00e9quilibrant le microbiote intestinal\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Un m\u00e9dicament pour r\u00e9\u00e9quilibrer le microbiote intestinal au CHUV","description":"Le CHUV a obtenu l\u2019autorisation de mise sur le march\u00e9 de Swissmedic pour produire un m\u00e9dicament de transplantation de microbiote f\u00e9cal (TMF).","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/","og_locale":"fr_FR","og_type":"article","og_title":"Un m\u00e9dicament pour r\u00e9\u00e9quilibrer le microbiote intestinal au CHUV","og_description":"Le CHUV a obtenu l\u2019autorisation de mise sur le march\u00e9 de Swissmedic pour produire un m\u00e9dicament de transplantation de microbiote f\u00e9cal (TMF).","og_url":"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2025-01-29T09:43:12+00:00","article_modified_time":"2025-01-29T09:52:06+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/CHUV-poop-medicine-1180x811-1.jpg","type":"image\/jpeg"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"Le CHUV produit le premier m\u00e9dicament suisse r\u00e9\u00e9quilibrant le microbiote intestinal","datePublished":"2025-01-29T09:43:12+00:00","dateModified":"2025-01-29T09:52:06+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/"},"wordCount":419,"commentCount":0,"image":{"@id":"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/CHUV-poop-medicine-1180x811-1.jpg","keywords":["Biotech","Education","Healthcare","Personalized Medicine","Pharma"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/","url":"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/","name":"Un m\u00e9dicament pour r\u00e9\u00e9quilibrer le microbiote intestinal au CHUV","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/CHUV-poop-medicine-1180x811-1.jpg","datePublished":"2025-01-29T09:43:12+00:00","dateModified":"2025-01-29T09:52:06+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"Le CHUV a obtenu l\u2019autorisation de mise sur le march\u00e9 de Swissmedic pour produire un m\u00e9dicament de transplantation de microbiote f\u00e9cal (TMF).","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/CHUV-poop-medicine-1180x811-1.jpg","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2025\/01\/CHUV-poop-medicine-1180x811-1.jpg","width":1180,"height":811,"caption":"Gr\u00e2ce \u00e0 la pr\u00e9cision suisse et \u00e0 une r\u00e9glementation rigoureuse, le CHUV veille \u00e0 ce que seuls les microbiotes les plus sains et les plus \u00e9quilibr\u00e9s soient utilis\u00e9s, permettant aux patients de retrouver un transit harmonieux et de tirer un trait sur leurs d\u00e9sagr\u00e9ments. | \u00a9 CHUV \/ Ganguillet Apicha"},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/le-chuv-produit-le-premier-medicament-suisse-reequilibrant-le-microbiote-intestinal\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"Le CHUV produit le premier m\u00e9dicament suisse r\u00e9\u00e9quilibrant le microbiote intestinal"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/30604","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=30604"}],"version-history":[{"count":4,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/30604\/revisions"}],"predecessor-version":[{"id":30611,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/30604\/revisions\/30611"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/30601"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=30604"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=30604"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=30604"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}